Europe Cardiovascular Devices Market

The Europe cardiovascular devices market is expected to reach US$ 22,973.31 million by 2028 from US$ 14,196.22 million in 2021. The market is estimated to grow at a CAGR of 7.1% from 2021 to 2028.

According to the European Cardiovascular Disease Statistics 2017, cardiovascular disease causes 3.9 million deaths in Europe and more than 1.8 million deaths annually in the European Union (EU). The disease accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. The European Society of Cardiology reported that patients suffering from atrial fibrillation are at a five-times greater risk of getting a stroke, and 20–30% of total stroke cases in Europe are caused due to atrial fibrillation. As per a study by the European Society of Cardiology in 2016, in the EU, ~7.6 million people aged 65 and above had atrial fibrillation, and the number is estimated to increase by 89% to reach ~14.4 million by 2060. The Europe cardiovascular devices market is expected to grow at a good CAGR during the forecast period.

Europe Cardiovascular Devices Revenue and Forecast to 2028 (US$ Million)

Get more information on this report Request Free Sample PDF

Europe Cardiovascular Devices Strategic Insights

Strategic insights for the Europe Cardiovascular Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Cardiovascular Devices Report Scope

Europe Cardiovascular Devices Regional Insights

The geographic scope of the Europe Cardiovascular Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Europe cardiovascular devices market is segmented into device, application, end user, and country. Based on device, the market is segmented into electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others. The event monitor segment dominated the market in 2020. Based on application, the Europe cardiovascular devices market is segmented into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease, and others. The coronary heart disease segment dominated the market in 2020. Based on end user, the market is segmented into hospitals, ambulatory surgery centers, and cardiac centers. The hospitals segment dominated the market in 2020. Based on country, the Europe cardiovascular devices market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe cardiovascular devices market in 2020.

Medtronic, Boston Scientific Corporation, Abbott, Johnson and Johnson Service Inc, General Electric Company, Koninklijke Philips N.V, Siemens Healthineers AG, BD, B. Braun Melsungen AG,and Edwards Lifesciences Corporation are among the leading companies in the Europe cardiovascular devices market.